Cardiology Headline News

BOSTON —Small interfering RNA technology has the potential to become a novel treatment approach in cardiovascular medicine, according to Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA.

BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

BOSTON — The recently launched PREVENT risk scoring algorithm has the ability to enhance the prevention and management of CVD, according to Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA.

BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.

BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.

Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.

AI accurately predicted several measures of cardiac function from coronary angiography that would otherwise require additional tests such as echocardiography or catheterization, a speaker reported.

TORONTO — Use of IV immunoglobulin with or without steroids was associated with reduced mortality among children with myocarditis compared with steroids alone, according to a study presented at the Pediatric Academic Societies Meeting.

A first-trimester algorithm that includes a blood test, ultrasound data and maternal characteristics predicted two-thirds of preterm preeclampsia and three-quarters of early-onset preeclampsia among nulliparous women, researchers reported.

ATLANTA — A system of standalone chest pain units set up in Karachi, Pakistan was associated with good metrics and outcomes for patients with STEMI who could not easily get to a hospital.